Terms: = Cervical cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
55 results:
1. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
2. Underestimated cervical cancer among Women over 65 Years Old: Is It Time to Revise the Screening Target Age Group?
Zago RA; Camilo-Júnior DJ; D'Ávilla SCGP; Xavier-Júnior JCC
Rev Bras Ginecol Obstet; 2023 Dec; 45(12):e790-e795. PubMed ID: 38141600
[TBL] [Abstract] [Full Text] [Related]
3. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
Peng Q; Wang L; Zuo L; Gao S; Jiang X; Han Y; Lin J; Peng M; Wu N; Tang Y; Tian H; Zhou Y; Liao Q
Cancer Gene Ther; 2024 Jan; 31(1):9-17. PubMed ID: 38102462
[TBL] [Abstract] [Full Text] [Related]
4. [Epidemiological Panorama of cervical Dysplasia in a First-Level Care Unit].
Seefoó-Jarquín P; Sosa-Jurado F; Maycotte-González P
Rev Med Inst Mex Seguro Soc; 2023 Mar; 61(2):155-162. PubMed ID: 37201194
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of miR-193a/b-3p during HPV-induced cervical carcinogenesis contributes to anchorage-independent growth through PI3K-akt pathway regulators.
Xu M; Huseinovic A; Jaspers A; Yuan L; Steenbergen RDM
J Med Virol; 2023 Mar; 95(3):e28589. PubMed ID: 36799263
[TBL] [Abstract] [Full Text] [Related]
6. Mechanistic analysis of endothelial lipase G promotion of the occurrence and development of cervical carcinoma by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase signalling pathway.
Huang J; Liu R; Zhang Y; Sheng X
J Obstet Gynaecol; 2023 Dec; 43(1):2151353. PubMed ID: 36606668
[TBL] [Abstract] [Full Text] [Related]
7. Ethnic disparity in cervical cancer stage at diagnosis: A retrospective study in an Israeli referral-center.
Levin G; Cohen L; Brandt B; Kogan L; Ben Simchon O; Perri T
Int J Gynaecol Obstet; 2023 Jun; 161(3):769-774. PubMed ID: 36565053
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of long-term sexual function of cervical cancer survivors after treatment: A cross-sectional study.
Wang HZ; He RJ; Zhuang XR; Xue YW; Lu Y
J Obstet Gynaecol Res; 2022 Nov; 48(11):2888-2895. PubMed ID: 36055894
[TBL] [Abstract] [Full Text] [Related]
9. In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer.
Xiang N; Chen T; Zhao X; Zhao M
Tissue Cell; 2022 Aug; 77():101845. PubMed ID: 35679681
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract] [Full Text] [Related]
11. Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial.
Chopra S; Goda JS; Mittal P; Mulani J; Pant S; Pai V; Kannan S; Deodhar K; Krishnamurthy MN; Menon S; Charnalia M; Shah S; Rangarajan V; Gota V; Naidu L; Sawant S; Thakkar P; Popat P; Ghosh J; Rath S; Gulia S; Engineer R; Mahantshetty U; Gupta S
BMJ Open; 2022 Apr; 12(4):e055765. PubMed ID: 35387819
[TBL] [Abstract] [Full Text] [Related]
12. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
[TBL] [Abstract] [Full Text] [Related]
13. cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
[TBL] [Abstract] [Full Text] [Related]
14. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
15. Perceptions of care after end-of-treatment among younger women with different gynecologic cancer diagnoses - a qualitative analysis of written responses submitted via a survey.
Mattsson E; Ljungman L; Einhorn K; Sundström Poromaa I; Stålberg K; Wikman A
BMC Womens Health; 2020 Dec; 20(1):276. PubMed ID: 33353541
[TBL] [Abstract] [Full Text] [Related]
16. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
[TBL] [Abstract] [Full Text] [Related]
17. Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-akt pathway in cancer therapy.
Amirani E; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B
Int J Biol Macromol; 2020 Dec; 164():456-467. PubMed ID: 32693135
[TBL] [Abstract] [Full Text] [Related]
18. [Evaluation the triage performance of p16/Ki-67 dual staining for HR-HPV positive women].
Jia MM; Zhao DM; Guo Z; Wu ZN; Chen PP; Guo PP; Sun XY; Zhang SK
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Feb; 54(2):192-197. PubMed ID: 32074709
[No Abstract] [Full Text] [Related]
19. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced cervical cancer and Potential for their Use in Blockade Therapy.
Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
[TBL] [Abstract] [Full Text] [Related]
20. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/akt pathway.
Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
[TBL] [Abstract] [Full Text] [Related]
[Next]
